"Flovent Inhaler Discontinuation in 2024: Impact on Availability and Pricing"

Flovent, a widely used asthma inhaler, is being discontinued by GSK in favor of an authorized generic version. This change has raised concerns among doctors and patients about insurance coverage and potential cost increases, despite the generic's lower cash price. Patients are advised to consult with their doctors and insurance companies to ensure continuity of care and to explore other medication options if necessary.